Spread the love

A recent study from the Laboratory of Gene Regulation and Signal Transduction, University of California, San Diego, La Jolla, California 92093; Departments of Pharmacology and Pathology, University of California, San Diego, La Jolla, California 92093; and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA shows that “A gp130-Src-YAP module links inflammation to epithelial regeneration.” This study was published in the 5 March  2015 issue of the Journal “Nature” [I.F:42] by Prof. Michael Karin, Dr. Koji Taniguchi, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based regenerative therapy for Injured tissues: MiRNA-518c promotes epithelial regeneration and tissue growth via downregulation of its target gene. Thus, pharmacological formulations encompassing “MiRNA-518c or its activators” may be used to promote regeneration and healing of injured tissues. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  MiRNA-based regenerative therapy for Injured tissues: MiRNA-518c promotes epithelial regeneration and tissue growth via downregulation of its target gene, 8/March/2015,  23.12,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How MiRNA-518c promotes regeneration of injured tissues.

Amount: $500*


Spread the love